fREMS for Mortality Prediction in TBI
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorAl-Nahrain University
About this trial
This prospective observational study aims to develop and internally validate a new clinical score, the FOUR-Rapid Emergency Medicine Score (fREMS), for predicting in-hospital mortality in patients with traumatic brain injury (TBI). The study will assess whether combining the Full Outline of UnResponsiveness (FOUR) score with physiological and clinical parameters from the Rapid Emergency Medicine Score (REMS) can improve early mortality prediction. The main question it aims to answer is:
Can the fREMS score accurately predict the risk of in-hospital mortality in patients with traumatic brain injury?
Data on demographic characteristics, vital signs, neurological assessment, and other relevant clinical variables will be collected from eligible patients with TBI and used to develop and validate the fREMS score.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with sufficient clinical data to calculate the fREMS score, including the FOUR Score and other required physiological variables.
Patients with a documented mortality outcome .
Disqualifiers
Patients transferred from another hospital after initial resuscitation.
Patients who died before the required initial clinical assessment
Trial population
The study population consisted of adult patients (≥16 years) with acute traumatic brain injury (TBI).
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
In hospital mortality
Mortality (death) during hospitalization
Time frame
In-Hospital Phase (average of 15 days through discharge)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: